Acquisition by Dorgan Byron L of 30120 shares of Codexis subject to Rule 16b-3
CDXS Stock | USD 5.63 0.18 3.10% |
Slightly above 64% of all Codexis' private investors are looking to take a long position. The analysis of overall sentiment of trading Codexis stock suggests that some investors are interested at this time. Codexis' investing sentiment can be driven by a variety of factors including economic data, Codexis' earnings reports, geopolitical events, and overall market trends.
Codexis |
Filed transaction by Codexis Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Cash Flow Correlation
Codexis' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Codexis' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Codexis Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Codexis can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Codexis Fundamental Analysis
We analyze Codexis' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Codexis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Codexis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Codexis is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Codexis Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Codexis stock to make a market-neutral strategy. Peer analysis of Codexis could also be used in its relative valuation, which is a method of valuing Codexis by comparing valuation metrics with similar companies.
Peers
Codexis Related Equities
MOLN | Molecular Partners | 0.73 | ||||
ANEB | Anebulo Pharmaceuticals | 0.72 | ||||
ADAG | Adagene | 0.47 | ||||
AVTE | Aerovate Therapeutics | 1.14 | ||||
MNOV | MediciNova | 1.38 | ||||
ACRV | Acrivon Therapeutics, | 5.65 | ||||
RZLT | Rezolute | 6.07 | ||||
IPSC | Century Therapeutics | 7.41 | ||||
STTK | Shattuck Labs | 9.77 |
Additional Tools for Codexis Stock Analysis
When running Codexis' price analysis, check to measure Codexis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Codexis is operating at the current time. Most of Codexis' value examination focuses on studying past and present price action to predict the probability of Codexis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Codexis' price. Additionally, you may evaluate how the addition of Codexis to your portfolios can decrease your overall portfolio volatility.